Helus Pharma Inc. (HELP) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Helus Pharma Inc. (HELP) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

HELP Income Statement

Helus Pharma Inc. (HELP) annual income statement — 10-year revenue, gross profit & net income history

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100%	-	-
Cost of Goods Sold	30.21K	0	0	0	0	0	0	0	0	0	142K	71K	69K	68K	71K	59K	53K	44K	44	42K
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-30.21K	0	0	0	0	0	0	0	0	0	-142K	-71K	-69K	-68K	-71K	-59K	-53K	-44K	-44	-42K
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-100%	-20.34%	-30.19%	-54.55%	-161263.64%	-40.48%	-39.47%	-6679.66%	-	-
Operating Expenses	47.81M	47.86M	41.18M	40.3M	24.62M	33.27M	32.2M	57.95M	14.85M	25.2M	26.88M	13.91M	13.39M	13.7M	12.09M	12.33M	13.39M	16.34M	16.45M	17.06M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	17.83M	18.97M	17.34M	14.01M	9.63M	14.3M	12.88M	48.89M	8.97M	13.35M	19.44M	6.93M	6.12M	5.61M	5.77M	6.9M	7.1M	10.33M	11.49M	12.37M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	29.98M	28.89M	23.84M	26.29M	14.99M	18.97M	19.32M	9.07M	5.88M	11.84M	7.44M	6.98M	6.59M	8.09M	6.26M	5.14M	6.05M	5.83M	4.96M	3.82M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-47.84M	-47.86M	-41.18M	-40.3M	-24.62M	-33.27M	-32.2M	-57.95M	-14.85M	-25.2M	-27.02M	-15.88M	-13.61M	-13.54M	-13.29M	-14.51M	-13.61M	-16.34M	-16.45M	-17.11M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-94.31%	-43.84%	-27.89%	30.46%	-65.79%	-32.06%	-	-	-	-	-103.39%	-9.45%	0%	17.14%	19.25%	15.19%	2.35%	-32.14%	-44.61%	-34883.74%
EBITDA	-47.81M	-47.83M	-41.15M	-40.26M	-24.59M	-33.21M	-32.06M	-57.81M	-14.75M	-25.05M	-26.88M	-15.81M	-13.54M	-13.47M	-13.22M	-14.45M	-13.56M	-16.29M	-16.45M	-17.06M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-94.4%	-44.02%	-28.36%	30.36%	-66.74%	-32.56%	-	-	-	-	-103.4%	-9.41%	0.12%	17.33%	19.68%	15.33%	2.47%	-32.17%	-44.77%	-779.27%
D&A (Non-Cash Add-back)	30.21K	31K	21.98K	40.45K	27.23K	62K	135.18K	142.5K	101K	142K	142K	71K	69K	68K	71K	59K	53K	44K	44	42K
EBIT	-47.84M	-47.86M	-41.18M	-40.3M	-24.62M	-33.27M	-32.2M	-57.95M	-14.85M	-25.2M	-27.02M	-13.91M	-12.71M	-13.7M	-12.09M	-12.33M	-13.39M	-18.1M	-16.45M	-17.11M
Net Interest Income	1.25M	1.58M	1.5M	1.49M	700.95K	1.44M	1.68M	3.06M	1.56M	342K	141K	52K	84K	148K	157K	174K	124K	83K	63K	51K
Interest Income	1.25M	1.58M	1.5M	1.49M	700.95K	1.44M	1.68M	3.06M	1.56M	342K	141K	52K	84K	148K	157K	174K	124K	83K	63K	51K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	1.23M	864K	-1.46M	-6.73M	11K	2.69M	21.35M	1.06M	4.01M	3.85M	-3.31M	2.02M	-1.81M	-17K	1.35M	2.35M	340K	-1.76M	-755K	-501K
Pretax Income	-46.6M	-46.99M	-42.63M	-47.03M	-24.61M	-30.58M	-10.84M	-56.9M	-10.83M	-21.35M	-30.33M	-11.89M	-14.51M	-13.72M	-10.74M	-9.97M	-13.05M	-18.1M	-17.21M	-17.61M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-46.6M	-46.99M	-42.63M	-47.03M	-24.61M	-30.58M	-10.84M	-56.9M	-10.83M	-21.35M	-30.33M	-11.89M	-12.38M	-13.72M	-10.74M	-9.97M	-13.05M	-18.1M	-17.21M	-17.61M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-89.4%	-53.68%	-293.23%	17.34%	-127.13%	-43.25%	-	-	-	-	-182.35%	-19.22%	5.21%	24.19%	37.58%	43.36%	11.29%	-31.35%	-50.71%	-35908.34%
Net Income (Continuing)	-46.6M	-46.99M	-42.63M	-47.03M	-24.61M	-30.58M	-10.84M	-56.9M	-10.83M	-21.35M	-30.33M	-11.89M	-14.51M	-13.72M	-10.74M	-9.97M	-13.05M	-18.1M	-17.21M	-17.61M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.89	-0.92	-1.76	-1.94	-1.10	-1.46	-0.54	-2.84	-0.55	-1.07	-0.24	-0.05	-0.06	-0.07	-0.06	-0.06	-0.07	-0.10	-0.10	-0.11
EPS Growth %	19.09%	36.99%	-225.93%	31.69%	-100%	-36.45%	-	-	-	-	-321.79%	7.99%	19.14%	30.1%	43.1%	49.91%	20.47%	-14.42%	0%	-
EPS (Basic)	-0.89	-0.92	-1.76	-1.94	-1.10	-1.46	-0.54	-2.84	-0.55	-1.07	-0.24	-0.05	-0.06	-0.07	-0.06	-0.06	-0.07	-0.10	-0.10	-0.11
Diluted Shares Outstanding	52.32M	50.29M	24.21M	24.21M	22.4M	20.9M	20M	20M	19.59M	20M	127.29M	234.58M	206.16M	196.14M	188.89M	180.84M	175.87M	173.76M	171.83M	165.78M
Basic Shares Outstanding	52.32M	50.29M	24.21M	24.21M	22.4M	20.9M	20M	20M	19.59M	20M	127.29M	234.58M	206.16M	196.14M	188.89M	180.84M	175.87M	173.76M	171.83M	165.78M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-